-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Amgen, Lowers Price Target to $430

Benzinga·10/12/2026 15:33:41
Listen to the news
Wells Fargo analyst Mohit Bansal maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and lowers the price target from $435 to $430.